Currently, the FDA allows the Pfizer vaccine to be given to people 16 years and older<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, April 12, 2021 (HealthDay News) — The Pfizer request to expand emergency use authorization of its COVID-19 vaccine to include children ages 12 to 15 years will be evaluated “as quickly as possible,” the U.S. Food and Drug Administration says.<\/p>\n
“While the FDA cannot predict how long our evaluation of the data and information will take, we will review the request as expeditiously as possible using our thorough and science-based approach,” FDA Acting Commissioner Janet Woodcock said on Twitter, CNN<\/em> reported.<\/p>\n Currently, the FDA allows the Pfizer vaccine to be given to people aged 16 years and older. Pfizer submitted a request to expand eligibility on Friday, and the company said it would seek similar approvals in other nations in the coming days.<\/p>\n The other two COVID-19 vaccines being used in the United States — from Moderna and Johnson & Johnson — are authorized for emergency use in people 18 years and older.<\/p>\n